Oncotype DX vs Foundation Medicine

Side-by-side comparison of cancer screening tests.

← Back to Cancer Screening

Oncotype DX

Guideline recommended
Variable

Breast recurrence risk

Foundation Medicine

FDA approved (CDx)
Variable

324 genes

Test Performance

FeatureOncotype DXFoundation Medicine
PriceVariableVariable
Cancers DetectedBreast recurrence risk324 genes
SensitivityN/AN/A
SpecificityN/AN/A
Sample TypeTumor tissueTumor tissue
FDA StatusGuideline recommendedFDA approved (CDx)